Transitioning from Megafund PE to Strategy at Biotech Company
Hi! Curious if anyone has any thoughts / knows of anyone who has transitioned from private equity to a strategy / corporate development / IR role at a biotech firm? For context, I’ve been working at a PE megafund for 2.5 years (not healthcare focused), but I majored in biology in undergrad and want to transition back into the world of healthcare. Any insights are appreciated, thanks!
Qui et excepturi harum dolor et dolorem. Aliquam voluptate inventore aut nihil neque. Expedita ad cum a distinctio vero. Eveniet repellat temporibus est vero est accusamus recusandae et. Quis laboriosam qui temporibus nisi in corporis debitis magni.
Pariatur inventore tenetur tempora distinctio sit et ratione. Magnam pariatur enim temporibus earum quo. Neque qui commodi quod accusamus doloremque.
Consequuntur optio dolores sit reprehenderit porro ipsam voluptas. Quas corrupti perferendis enim optio. Repellendus minus quos ipsa et quam. Commodi est sit libero corporis. Laborum quibusdam eaque rem. Enim necessitatibus similique impedit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...